Kurosu, Tetsuya <br/><br/>
BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells.  [electronic resource] 

 -  Oncogene  Jul 2003 
 - 4459-68 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1206755  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcysteine--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Antioxidants--pharmacology<br/>Apoptosis--drug effects<br/>Cysteine Endopeptidases--drug effects<br/>Cysteine Proteinase Inhibitors--pharmacology<br/>DNA-Binding Proteins--drug effects<br/>Doxycycline--pharmacology<br/>Etoposide--pharmacology<br/>Free Radical Scavengers--pharmacology<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Leupeptins--pharmacology<br/>Lymphoma, B-Cell--drug therapy<br/>Membrane Potentials--drug effects<br/>Mitochondria--drug effects<br/>Multienzyme Complexes--antagonists & inhibitors<br/>Mutation<br/>Proteasome Endopeptidase Complex<br/>Proto-Oncogene Proteins--drug effects<br/>Proto-Oncogene Proteins c-bcl-6<br/>Reactive Oxygen Species--metabolism<br/>Transcription Factors--drug effects<br/>Tumor Cells, Cultured